We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.05%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$79.6B
AUM Growth
+$3.14B
(+4.1%)
Cap. Flow
-$261M
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
28.43%
Holding
1,306
New
82
Increased
428
Reduced
567
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ares Management
ARES
|
+$482M |
| 2 |
GE Aerospace
GE
|
+$294M |
| 3 |
Ferguson
FERG
|
+$291M |
| 4 |
Intuitive Surgical
ISRG
|
+$201M |
| 5 |
West Pharmaceutical
WST
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$652M |
| 2 |
Atlassian
TEAM
|
+$615M |
| 3 |
Blackstone
BX
|
+$497M |
| 4 |
Estee Lauder
EL
|
+$201M |
| 5 |
ServiceNow
NOW
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.84% |
| 2 | Financials | 17.52% |
| 3 | Healthcare | 12.51% |
| 4 | Industrials | 9.88% |
| 5 | Consumer Discretionary | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Labcorp
LH
$24.3B
| $13.4M | 0.02% |
60,176
+4,586
| +8% | +$1.01M |
|
|
NVO
377
Novo Nordisk
NVO
$216B
| $13.3M | 0.02% |
111,954
-3,037
| -3% | -$405K |
|
378
Insulet
PODD
$11.3B
| $13.3M | 0.02% |
57,233
+8,132
| +17% | +$1.67M |
|
379
iShares Russell 3000 ETF
IWV
$19.5B
| $13.3M | 0.02% |
40,723
-75
| -0.2% | -$23.6K |
|
380
Oneok
OKE
$58.7B
| $13.2M | 0.02% |
145,096
-802
| -0.5% | -$69.8K |
|
|
BNY
381
Bank of New York Mellon
BNY
$108B
| $13M | 0.02% |
181,155
-4,569
| -2% | -$301K |
|
382
Nike
NKE
$61.9B
| $12.8M | 0.02% |
145,358
-16,961
| -10% | -$1.33M |
|
383
Brookfield Infrastructure Partners
BIP
$18.8B
| $12.8M | 0.02% |
366,394
-12,799
| -3% | -$402K |
|
384
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
| $12.8M | 0.02% |
250,807
-31,606
| -11% | -$1.6M |
|
385
Prologis
PLD
$138B
| $12.7M | 0.02% |
100,443
+1,498
| +2% | +$186K |
|
386
CSX Corp
CSX
$98.6B
| $12.7M | 0.02% |
366,464
-106,333
| -22% | -$3.61M |
|
387
Quanta Services
PWR
$93.9B
| $12.6M | 0.02% |
42,336
-2,125
| -5% | -$562K |
|
388
Immunome
IMNM
$2.52B
| $12.6M | 0.02% |
860,779
+178,390
| +26% | +$2.53M |
|
389
Vulcan Materials
VMC
$36.3B
| $12.5M | 0.02% |
50,012
-549
| -1% | -$136K |
|
390
Vanguard Real Estate ETF
VNQ
$39.9B
| $12.5M | 0.02% |
128,005
-17,845
| -12% | -$1.64M |
|
391
Vanguard Extended Market ETF
VXF
$30.3B
| $12.4M | 0.02% |
68,405
-1,151
| -2% | -$201K |
|
392
Ross Stores
ROST
$76.6B
| $12.2M | 0.02% |
81,323
+301
| +0.4% | +$44.4K |
|
393
Altria Group
MO
$122B
| $12.2M | 0.02% |
239,796
+48,155
| +25% | +$2.43M |
|
394
iShares Biotechnology ETF
IBB
$9.31B
| $12.1M | 0.02% |
82,805
-79
| -0.1% | -$11.4K |
|
395
Booz Allen Hamilton
BAH
$8.7B
| $12M | 0.02% |
73,582
-1,378
| -2% | -$211K |
|
396
HEICO Corp Class A
HEI.A
$35.4B
| $11.9M | 0.02% |
58,478
-1,856
| -3% | -$352K |
|
397
Eaton
ETN
$157B
| $11.9M | 0.01% |
35,851
-702
| -2% | -$214K |
|
398
Bristol-Myers Squibb
BMY
$127B
| $11.8M | 0.01% |
228,373
-3,524
| -2% | -$165K |
|
399
Star Group
SGU
$428M
| $11.8M | 0.01% |
1,001,800
+48,113
| +5% | +$546K |
|
400
Truist Financial
TFC
$63.2B
| $11.7M | 0.01% |
273,852
-16,060
| -6% | -$678K |
|
Similar funds
QCM
Brown Advisory's Q3 2024 Portfolio in Review
As of Q3 2024, Brown Advisory held 1,306 positions worth $79.6B, up 4.1% from $76.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Brown Advisory's Q3 2024 filing shows 82 new, 428 increased, 567 reduced and 48 closed positions. Its largest new stake was Talen Energy Corp: 626,841 shares worth $112M. The largest sale was Edwards Lifesciences, an estimated $652M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Healthcare.
- Brown Advisory's largest Q3 2024 buy was Talen Energy Corp: 626,841 shares worth $112M.
- Brown Advisory added most to Ares Management in Q3 2024, an estimated $482M increase.
- Brown Advisory's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $652M.
- Brown Advisory fully exited Blackrock in Q3 2024, selling an estimated $66.6M.
- Brown Advisory's ten largest holdings make up 28% of its $79.6B portfolio in Q3 2024.
- Brown Advisory opened 82 new positions and closed 48 in Q3 2024.
- Brown Advisory's portfolio value rose 4.1% quarter-over-quarter to $79.6B.
Based on Brown Advisory's 13F filing for Q3 2024, filed 13 Nov 2024.